[1]
|
Liu, L.-N., Li, X.-M., Ye, D.-Q. and Pan, H.-F. (2018) Emerging Role of Semaphorin-3A in Autoimmune Diseases. Inflammopharmacology, 26, 655-665. https://doi.org/10.1007/s10787-018-0484-y
|
[2]
|
Vadasz, Z. and Toubi, E. (2014) Semaphorins: Their Dual Role in Regulating Immune-Mediated Diseases. Clinical Reviews in Allergy & Immunology, 47, 17-25. https://doi.org/10.1007/s12016-013-8360-4
|
[3]
|
李军, 蔡玉桂, 杨志刚. Sema分子家族在免疫调节中作用的最新进展[J]. 海南医学, 2016(3): 434-437.
|
[4]
|
Angelopoulou, E. and Piperi, C. (2018) Emerging Role of Plexins Signaling in Glioma Progression and Therapy. Cancer Letters, 414, 81-87. https://doi.org/10.1016/j.canlet.2017.11.010
|
[5]
|
Toubi, E. and Vadasz, Z. (2020) Semaphorin-3A Is a Promising Therapeutic Tool for Bronchial Asthma. Allergy, 75, 481-483. https://doi.org/10.1111/all.14026
|
[6]
|
Suzuki, K., Kumanogoh, A. and Kikutani, H. (2008) Semaphorins and Their Receptors in Immune Cell Interactions. Nature Immunology, 9, 17-23. https://doi.org/10.1038/ni1553
|
[7]
|
Vadasz, Z. and Toubi, E. (2018) Semaphorin-3A: A Potential Therapeutic Tool in Immune-Mediated Diseases. European Journal of Rheumatology, 5, 58-61. https://doi.org/10.5152/eurjrheum.2017.17076
|
[8]
|
Rimar, D., Rosner, I., Slobodin, G., Rozenbaum, M., Halasz, K., Jiries, N., Kaly, L., Boulman, N. and Vadasz, Z. (2016) Semaphorin 3A, a Potential Immune Regulator in Familial Mediterranean Fever. Clinical and Experimental Rheumatology, 34, S52-S55. https://doi.org/10.1186/1546-0096-13-S1-O46
|
[9]
|
Lepelletier, Y., Moura, I.C., Hadj-Slimane, R., Renand, A., Fiorentino, S., Baude, C., Shirvan, A., Barzilai, A. and Hermine, O. (2006) Immunosuppressive Role of Semaphorin-3A on T Cell Proliferation Is Mediated by Inhibition of Actin Cytoskeleton Reorganization. European Journal of Immunology, 36, 1782-1793. https://doi.org/10.1002/eji.200535601
|
[10]
|
Vadasz, Z. and Toubi, E. (2012) Semaphorin 3A—A Marker for Disease Activity and a Potential Putative Disease- Modifying Treatment in Systemic Lupus Erythematosus. Lupus, 21, 1266-1270.
https://doi.org/10.1177/0961203312456753
|
[11]
|
Catalano, A., Caprari, P., Moretti, S., Faronato, M., Tamagnone, L. and Procopio, A. (2006) Semaphorin-3A Is Expressed by Tumor Cells and Alters T-Cell Signal Transduction and Function. Blood, 107, 3321-3329.
https://doi.org/10.1182/blood-2005-06-2445
|
[12]
|
Kikutani, H. and Kumanogoh, A. (2003) Semaphorins in Interactions between T Cells and Antigen-Presenting Cells. Nature Reviews Immunology, 3, 159-167. https://doi.org/10.1038/nri1003
|
[13]
|
Dustin, M.L. and Cooper, J.A. (2000) The Immunological Synapse and the Actin Cytoskeleton: Molecular Hardware for T Cell Signaling. Nature Immunology, 1, 23-29. https://doi.org/10.1038/76877
|
[14]
|
Fuller, C.L., Braciale, V.L. and Samelson, L.E. (2003) All Roads Lead to Actin: The Intimate Relationship between TCR Signaling and the Cytoskeleton. Immunological Reviews, 191, 220-236.
https://doi.org/10.1034/j.1600-065X.2003.00004.x
|
[15]
|
Lowin-Kropf, B., Shapiro, V.S. and Weiss, A. (1998) Cytoskeletal Polarization of T Cells Is Regulated by an Immunoreceptor Tyrosine-Based Activation Motif-Dependent Mechanism. Journal of Cell Biology, 140, 861-871.
https://doi.org/10.1083/jcb.140.4.861
|
[16]
|
Wu, H.J. and Bondada, S. (2002) Positive and Negative Roles of CD72 in B Cell Function. Immunologic Research, 25, 155-166. https://doi.org/10.1385/IR:25:2:155
|
[17]
|
Adachi, T., Wakabayashi, C., Nakayama, T., Yakura, H. and Tsubata, T. (2000) CD72 Negatively Regulates Signaling through the Antigen Receptor of B Cells. The Journal of Immunology, 164, 1223-1229.
https://doi.org/10.4049/jimmunol.164.3.1223
|
[18]
|
Tsubata, T. (2019) CD72 Is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-Antigens and Development of Systemic Lupus Erythematosus. Immune Network, 19, e1. https://doi.org/10.4110/in.2019.19.e1
|
[19]
|
Vadasz, Z., Haj, T., Balbir, A., Peri, R., Rosner, I., Slobodin, G., Kessel, A. and Toubi, E. (2014) A Regulatory Role for CD72 Expression on B Cells in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 43, 767-771.
https://doi.org/10.1016/j.semarthrit.2013.11.010
|
[20]
|
Vadasz, Z., Haj, T. and Toubi, E. (2014) The Role of B Regulatory Cells and Semaphorin-3A in Atopic Diseases. International Archives of Allergy and Immunology, 163, 245-251. https://doi.org/10.1159/000360477
|
[21]
|
Takamatsu, H., Takegahara, N., Nakagawa, Y., Tomura, M., Taniguchi, M., Friedel, R.H., Rayburn, H., Tessier-Lavigne, M., Yoshida, Y., Okuno, T., Mizui, M., Kang, S., Nojima, S., Tsujimura, T., Nakatsuji, Y., Katayama, I., Toyofuku, T., Kikutani, H. and Kumanogoh, A. (2010) Semaphorins Guide the Entry of Dendritic Cells into the Lymphatics by Activating Myosin II. Nature Immunology, 11, 594-600. https://doi.org/10.1038/ni.1885
|
[22]
|
Friedl, P. and Weigelin, B. (2008) Interstitial Leukocyte Migration and Immune Function. Nature Immunology, 9, 960-969. https://doi.org/10.1038/ni.f.212
|
[23]
|
Lämmermann, T. and Sixt, M. (2009) Mechanical Modes of “Amoeboid” Cell Migration. Current Opinion in Cell Biology, 21, 636-644. https://doi.org/10.1016/j.ceb.2009.05.003
|
[24]
|
Lombardi, M.L., Knecht, D.A., Dembo, M. and Lee, J. (2007) Traction Force Microscopy in Dictyostelium Reveals Distinct Roles for Myosin II Motor and Actin-Crosslinking Activity in Polarized Cell Movement. Journal of Cell Science, 120, 1624-1634. https://doi.org/10.1242/jcs.002527
|
[25]
|
Hartmann, S., Ridley, A.J. and Lutz, S. (2015) The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease. Frontiers in Pharmacology, 6, 276. https://doi.org/10.3389/fphar.2015.00276
|
[26]
|
Lins, M.P., Silva, E.C.O., Silva, G.R., Souza, S.T., Medeiros, N.C., Fonseca, E.J.S. and Smaniotto, S. (2018) Association between Biomechanical Alterations and Migratory Ability of Semaphorin-3A-Treated Thymocytes. Biochimica et Biophysica Acta—General Subjects, 1862, 816-824. https://doi.org/10.1016/j.bbagen.2018.01.001
|
[27]
|
Lins, M.P., Medeiros, N.C., Carmo, J., Porto, F.L., Reis, D.S. and Smaniotto, S. (2020) The Responsiveness of Thymic Stromal Cells to Semaphorin-3A. Immunological Investigations, 1-16. https://doi.org/10.1080/08820139.2020.1834578
|
[28]
|
Rienks, M., Carai, P., Bitsch, N., Schellings, M., Vanhaverbeke, M., Verjans, J., Cuijpers, I., Heymans, S. and Papageorgiou, A. (2017) Sema3A Promotes the Resolution of Cardiac Inflammation after Myocardial Infarction. Basic Research in Cardiology, 112, 42. https://doi.org/10.1007/s00395-017-0630-5
|
[29]
|
Ji, J.D., Park-Min, K.H. and Ivashkiv, L.B. (2009) Expression and Function of Semaphorin 3A and Its Receptors in Human Monocyte-Derived Macrophages. Human Immunology, 70, 211-217.
https://doi.org/10.1016/j.humimm.2009.01.026
|
[30]
|
Bakke, A.C., Kirkland, P.A., Kitridou, R.C., Quismorio, F.P., Rea, T., Ehresmann, G.R. and Horwitz, D.A. (1983) T Lymphocyte Subsets in Systemic Lupus Erythematosus. Correlations with Corticosteroid Therapy and Disease Activity. Arthritis & Rheumatology, 26, 745-750. https://doi.org/10.1002/art.1780260607
|
[31]
|
André, S., Tough, D.F., Lacroix-Desmazes, S., Kaveri, S.V. and Bayry, J. (2009) Surveillance of Antigen-Presenting Cells by CD4+ CD25+ Regulatory T Cells in Autoimmunity: Immunopathogenesis and Therapeutic Implications. The American Journal of Pathology, 174, 1575-1587. https://doi.org/10.2353/ajpath.2009.080987
|
[32]
|
Catalano, A. (2010) The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis. The Journal of Immunology, 185, 6373-6383. https://doi.org/10.4049/jimmunol.0903527
|
[33]
|
Negishi-Koga, T. and Takayanagi, H. (2012) Bone Cell Communication Factors and Semaphorins. BoneKEy Reports, 1, 183. https://doi.org/10.1038/bonekey.2012.183
|
[34]
|
Rimar, D., Nov, Y., Rosner, I., Slobodin, G., Rozenbaum, M., Halasz, K., Haj, T., Jiries, N., Kaly, L., Boulman, N. and Vadasz, Z. (2015) Semaphorin 3A: An Immunoregulator in Systemic Sclerosis. Rheumatology International, 35, 1625- 1630. https://doi.org/10.1007/s00296-015-3269-2
|